Tiziana Life Sciences

$6.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.51 (-7.35%) Today
$0.00 (0.00%) As of 3:51 PM EDT after-hours

Why Robinhood?

You can buy or sell TLSA and other stocks, options, ETFs, and crypto commission-free!

About TLSA

Tiziana Life Sciences plc American Depository Share, also called Tiziana Life Sciences, is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. Read More The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.

Employees
10
Headquarters
London, Greater London
Founded
2013
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
1.37K
High Today
$6.69
Low Today
$6.27
Open Price
$6.27
Volume
1.23K
52 Week High
$12.17
52 Week Low
$5.00

Collections

TLSA Earnings

Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 28, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.